Category: Pharmaceuticals - Page 2

How FDA Approval Costs for Generic Drugs Impact Healthcare Prices
Dec, 2 2025

How FDA Approval Costs for Generic Drugs Impact Healthcare Prices

FDA approval costs for generic drugs are high and slow, delaying affordable medications. Learn how fees, reformulation delays, and policy changes impact drug prices and patient access.

How Insurer-Pharmacy Negotiations Set Generic Drug Prices
Dec, 1 2025

How Insurer-Pharmacy Negotiations Set Generic Drug Prices

Generic drug prices are set not by pharmacies or insurers, but by middlemen called PBMs using opaque formulas. Learn how spread pricing, gag clauses, and clawbacks drive up costs-even when you have insurance.

Triptans and SSRIs: The Truth Behind the Serotonin Syndrome Myth
Dec, 1 2025

Triptans and SSRIs: The Truth Behind the Serotonin Syndrome Myth

Triptans and SSRIs are often wrongly thought to cause serotonin syndrome. Evidence shows the risk is negligible. Learn why doctors now safely prescribe them together for migraine and depression.

Dapoxetine vs Alternatives: What Works Best for Premature Ejaculation?
Dec, 1 2025

Dapoxetine vs Alternatives: What Works Best for Premature Ejaculation?

Dapoxetine is a leading treatment for premature ejaculation, but it's not the only option. Compare it with SSRIs, topical sprays, and behavioral techniques to find what works best for you.

Future of Global Generic Markets: Key Predictions and Trends Through 2030
Nov, 27 2025

Future of Global Generic Markets: Key Predictions and Trends Through 2030

The global generic drugs market is shifting from low-cost volume to high-stakes innovation. Biosimilars, supply chain risks, and emerging markets are reshaping affordability and access by 2030.

Combination Drug Substitution: Legal and Practical Challenges Explained
Nov, 25 2025

Combination Drug Substitution: Legal and Practical Challenges Explained

Combination drug substitution is legally complex and risky. While cost-saving substitutions are common, mixing or swapping multi-drug pills without proper oversight can endanger patients. Here’s how laws, pharmacy practices, and regulations are struggling to keep up.

FDA Safety Communications Archive: How to Research Historical Drug and Device Warnings
Nov, 22 2025

FDA Safety Communications Archive: How to Research Historical Drug and Device Warnings

Learn how to use the FDA Safety Communications Archive to research historical drug and medical device warnings. Access official alerts, labeling changes, and safety data from 2010 to 2024.

GLP-1 Agonists for Weight Loss: Real Benefits and Common Side Effects
Nov, 19 2025

GLP-1 Agonists for Weight Loss: Real Benefits and Common Side Effects

GLP-1 agonists like Wegovy and Zepbound offer powerful weight loss-up to 21% of body weight-but come with side effects like nausea and high costs. Learn how they work, who they’re for, and what to expect.

How Insurance Plans Use Generic Drugs to Lower Prescription Costs
Nov, 18 2025

How Insurance Plans Use Generic Drugs to Lower Prescription Costs

Insurance plans use tiered formularies, mandatory substitution, and step therapy to steer patients toward generic drugs, saving billions annually. But hidden PBM pricing practices can prevent patients from seeing the full savings.

Progressive Multifocal Leukoencephalopathy Risk from Immunosuppressants: What You Need to Know
Nov, 18 2025

Progressive Multifocal Leukoencephalopathy Risk from Immunosuppressants: What You Need to Know

PML is a rare but deadly brain infection triggered by the JC virus in people on immunosuppressants. Learn which drugs carry the highest risk, how to monitor for early signs, and what steps can save your life.